Free Trial

U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Riverbridge Partners LLC

U.S. Physical Therapy logo with Medical background

Riverbridge Partners LLC decreased its stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 8.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 283,261 shares of the company's stock after selling 26,949 shares during the period. Riverbridge Partners LLC owned approximately 1.86% of U.S. Physical Therapy worth $20,497,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. CBIZ Investment Advisory Services LLC increased its holdings in U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after acquiring an additional 122 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in U.S. Physical Therapy during the 4th quarter valued at about $39,000. Venturi Wealth Management LLC increased its holdings in U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after acquiring an additional 704 shares in the last quarter. Lazard Asset Management LLC purchased a new position in U.S. Physical Therapy during the 4th quarter valued at about $84,000. Finally, Fifth Third Bancorp increased its holdings in U.S. Physical Therapy by 34.6% during the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock valued at $75,000 after acquiring an additional 265 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on USPH. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. JPMorgan Chase & Co. lowered their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th. Wall Street Zen upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. JMP Securities reiterated a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Finally, Barrington Research lowered their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a report on Friday, February 28th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $109.00.

View Our Latest Research Report on USPH

U.S. Physical Therapy Trading Up 1.5%

Shares of NYSE USPH traded up $1.15 during midday trading on Monday, reaching $75.43. 242,865 shares of the stock were exchanged, compared to its average volume of 117,385. The company has a market capitalization of $1.15 billion, a P/E ratio of 34.60, a P/E/G ratio of 3.60 and a beta of 1.45. U.S. Physical Therapy, Inc. has a 52-week low of $62.77 and a 52-week high of $101.20. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.32. The stock has a 50 day moving average price of $74.04 and a 200-day moving average price of $80.32.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The firm had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. During the same period in the previous year, the firm earned $0.51 earnings per share. U.S. Physical Therapy's revenue was up 18.0% compared to the same quarter last year. Equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 23rd were issued a $0.45 dividend. The ex-dividend date of this dividend was Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a yield of 2.39%. U.S. Physical Therapy's payout ratio is 82.57%.

Insider Activity at U.S. Physical Therapy

In related news, Director Nancy Ham sold 400 shares of the business's stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the sale, the director now directly owns 2,594 shares in the company, valued at approximately $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is owned by insiders.

U.S. Physical Therapy Profile

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Recommended Stories

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines